E-viri
PDF
Recenzirano
Odprti dostop
-
Burke, Carol A; Dekker, Evelien; Lynch, Patrick; Samadder, N. Jewel; Balaguer, Francesc; Hüneburg, Robert; Burn, John; Castells, Antoni; Gallinger, Steven; Lim, Ramona; Stoffel, Elena M; Gupta, Samir; Henderson, Alex; Kallenberg, Frank G; Kanth, Priyanka; Roos, Victorine H; Ginsberg, Gregory G; Sinicrope, Frank A; Strassburg, Christian P; Van Cutsem, Eric; Church, James; Lalloo, Fiona; Willingham, Field F; Wise, Paul E; Grady, William M; Ford, Molly; Weiss, Jennifer M; Gryfe, Robert; Rustgi, Anil K; Syngal, Sapna; Cohen, Alfred
The New England journal of medicine, 09/2020, Letnik: 383, Številka: 11Journal Article
In randomized trial involving 171 adults with familial adenomatous polyposis, the incidence of disease progression was not significantly lower with combination therapy with eflornithine (an inhibitor of ornithine decarboxylase) and sulindac (an NSAID) than with either drug alone.
